Stephen W. Macmahon

Stephen W. Macmahon's AcademicInfluence.com Rankings

Stephen W. Macmahon

Medical

#1306

World Rank

#1632

Historical Rank

Cardiology

#90

World Rank

#92

Historical Rank

medical Degrees

Stephen W. Macmahon

Philosophy

#4235

World Rank

#6682

Historical Rank

Logic

#1742

World Rank

#2578

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Stephen W. Macmahon's Degrees

PhD Biochemistry Stanford University

Why Is Stephen W. Macmahon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephen W. Macmahon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. (1998) (5391)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias (1990) (4608)
Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context (1990) (4606)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack (2001) (2412)
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials (2000) (2202)
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials (2000) (1778)
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction (1995) (1755)
Severe hypoglycemia and risks of vascular events and death. (2010) (1317)
Interpretation of the evidence for the efficacy and safety of statin therapy (2016) (1290)
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000) (962)
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. (2003) (930)
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis (2016) (826)
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. (2005) (810)
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials (2008) (686)
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. (1994) (607)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment (2013) (605)
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. (1991) (585)
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. (1999) (557)
Blood pressure, cholesterol, and stroke in eastern Asia (1998) (553)
Blood pressure and cardiovascular disease in the Asia Pacific region (2003) (550)
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data (2014) (449)
Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy (2005) (445)
Alcohol consumption and hypertension. (1987) (417)
Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease (1997) (382)
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. (2003) (382)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. (2001) (361)
Diabetes and the risk of stroke. The Honolulu Heart Program. (1987) (358)
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. (1986) (356)
The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. (1986) (354)
1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS (1988) (329)
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease (1995) (328)
The burden of blood pressure-related disease: a neglected priority for global health. (2007) (328)
Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden (2006) (322)
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials (2001) (320)
Risk prediction in patients with heart failure: a systematic review and analysis. (2014) (315)
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system (2007) (314)
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial (2006) (308)
Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. (1988) (307)
The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. (2003) (301)
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds (2012) (297)
Blood pressure and risk of stroke in patients with cerebrovascular disease (1996) (276)
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes (2009) (265)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial (2003) (253)
Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis Results of the LIPID Atherosclerosis Substudy (1998) (247)
Blood Pressure and Mortality Among Men With Prior Myocardial Infarction (1995) (245)
Obesity and hypertension: epidemiological and clinical issues. (1987) (245)
Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. (1997) (244)
Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up (2002) (240)
Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. (2000) (237)
Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies (2001) (236)
Management of raised blood pressure in New Zealand: a discussion document. (1993) (235)
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. (1999) (234)
Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis (2014) (231)
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. (2008) (226)
Estimation of Arterial Stiffness, Compliance, and Distensibility From M‐Mode Ultrasound Measurements of the Common Carotid Artery (1994) (210)
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials (2013) (203)
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials (2011) (203)
Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial (2001) (200)
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials (1996) (197)
Obesity, alcohol consumption and blood pressure in Australian men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. (1984) (190)
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial (2010) (188)
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2009) (187)
The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. (1993) (186)
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. (2006) (184)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2013) (177)
The epidemiology of blood pressure and its worldwide management. (2015) (172)
Pravastatin therapy and the risk of stroke. (2000) (170)
Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis (2011) (166)
Reducing the global burden of blood pressure-related cardiovascular disease. (2000) (165)
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
Blood pressure, antihypertensive treatment and stroke risk. (1994) (160)
Global inequalities in access to cardiovascular health care: our greatest challenge. (2008) (159)
Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels (2006) (154)
1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
Alcohol consumption and the risk of alcohol related cirrhosis in women. (1987) (150)
Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke (2008) (145)
COMPARISON OF WEIGHT REDUCTION WITH METOPROLOL IN TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS (1985) (145)
Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. (1997) (145)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition (2003) (136)
Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. (1997) (131)
Plasma Lipoprotein Levels in Treated and Untreated Hypertensive Men and Women: The National Heart Foundation of Australia Risk Factor Prevalence Study (1985) (127)
Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke (2005) (125)
Incidence of heterotopic bone formation after major hip surgery (2002) (125)
A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery (2000) (118)
The effects of antihypertensive treatment on vascular disease: Reappraisal of the evidence in 1994 (1993) (117)
B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. (1993) (116)
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies (2018) (115)
Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. (1989) (113)
Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. (1995) (111)
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. (2001) (107)
Hypertension: comparison of drug and non-drug treatments. (1982) (106)
APOE genotype, ethnicity, and the risk of cerebral hemorrhage (2008) (105)
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. (2007) (104)
Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History (2009) (102)
High prevalence of chronic kidney disease in Thailand. (2008) (99)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis (2012) (98)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India (2014) (97)
Blood pressure and the risk of cardiovascular disease. (2000) (96)
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. (1994) (95)
International Society of Hypertension (ISH): Statement on Blood Pressure Lowering and Stroke Prevention (2003) (93)
Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial (2015) (93)
Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China. (2016) (90)
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack (2005) (89)
Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial (2006) (83)
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study (2000) (83)
Mitral valve prolapse and infective endocarditis. (1987) (83)
Mitral valve prolapse and bacterial endocarditis: when is antibiotic prophylaxis necessary? (1984) (82)
Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-91. (1995) (82)
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. (2010) (81)
Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease (2005) (81)
Association of environmental tobacco smoke exposure with socioeconomic status in a population of 7725 New Zealanders. (1998) (81)
Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. Commentary (2006) (80)
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. (1995) (79)
The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. (2012) (78)
Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare (2017) (77)
Reductions in the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial (2004) (76)
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
Beta-blockers in heart failure: promising or proved? (1994) (73)
Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India (2009) (71)
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease (2007) (71)
Cardiovascular risk factor levels in urban and rural Thailand--The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). (2003) (69)
Motor vehicle driver injury and socioeconomic status: a cohort study with prospective and retrospective driver injuries (2003) (69)
Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial (2013) (68)
Antihypertensive Drug Treatment Potential, Expected, and Observed Effects on Stroke and on Coronary Heart Disease (1989) (68)
The Epidemiological Association between Blood Pressure and Stroke: Implications for Primary and Secondary Prevention (1994) (67)
Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study. (1986) (67)
International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. (2004) (66)
Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial (2006) (66)
ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline (2005) (66)
Cholesterol and total mortality: need for larger trials. (1992) (65)
Blood-pressure-related disease is a global health priority. (2008) (64)
Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. (1987) (64)
Systematic Underestimation of Treatment Effects as a Result of Diagnostic Test Inaccuracy: Implications for the Interpretation and Design of Thromboprophylaxis Trials (1995) (63)
Effect of Intravenous Nitrates on Mortality in Acute Myocardial Infarction (1993) (63)
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. (2009) (62)
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group. (1995) (59)
Obesity as a risk factor for COVID‐19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease (2020) (58)
REDUCTION IN MAJOR MORBIDITY AND MORTALITY BY HEPARIN IN ACUTE MYOCARDIAL-INFARCTION (1989) (57)
The world health organization—International society of hypertension blood pressure lowering treatment trialists’ collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments (1999) (56)
Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults (2016) (56)
Determinants of cardiovascualar disease in the Asia Pacific region: protocol for a collaborative overview of cohort studies (1999) (56)
Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke (2013) (55)
The Effects of a Community-Based Sodium Reduction Program in Rural China – A Cluster-Randomized Trial (2016) (55)
The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock. (2010) (53)
Reliable assessment of the effects of treatments on mortality and major morbidity (2007) (52)
Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findings. (1995) (51)
Hypertension—time to move on (2005) (51)
Blood pressure and the prevention of stroke (1996) (50)
Major clinical trials of hypertension: what should be done next? (2005) (50)
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region (2004) (49)
Leg ulceration and perceived health: a population based case-control study. (2004) (49)
Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial (2012) (49)
Left ventricular mass correlates with fat-free mass but not fat mass in adults. (1999) (49)
Mortality after hip fracture: regional variations in New Zealand. (1999) (48)
Random errors in the measurement of 10 cardiovascular risk factors (2004) (47)
The effects of diabetes mellitus on the risks of major cardiovascular diseases and death in the Asia-Pacific region (Journal article) (2003) (47)
The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. (2014) (47)
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (2011) (47)
Motor vehicle driver injury and marital status: a cohort study with prospective and retrospective driver injuries (2004) (46)
Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. (1986) (45)
Chronic suppurative osteomyelitis of the mandible: case report. (2005) (45)
Is body mass index a risk factor for motor vehicle driver injury? A cohort study with prospective and retrospective outcomes. (2003) (44)
Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. (2005) (44)
Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease (2005) (44)
Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. (1997) (44)
Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults (2018) (43)
No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients (2000) (43)
The Treatment of cardiovascular Risk in Primary care using Electronic Decision suppOrt (TORPEDO) study: intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare (2012) (42)
Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. (2006) (41)
Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. (2008) (40)
Blood-pressure-related disease is a global health priority. (2008) (40)
Blood pressure and coronary heart disease (1990) (40)
Global burden of blood pressure-related disease (1999) (1999) (40)
The global burden of hypertension (2001) (38)
Effects of different blood pressure lowering regimens on major cardiovascular events: second cycle of prospectively designed overviews (2003) (38)
Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group. (1997) (36)
Alcohol and hypertension: implications for prevention and treatment. (1986) (36)
Blood-pressure-related disease is a global health priority (2008) (36)
SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India (2019) (35)
The occurrence of leg ulcers in Auckland: results of a population-based study. (2002) (35)
Verbal autopsy coding: are multiple coders better than one? (2009) (34)
Socioeconomic distribution of smoking in a population of 10,529 New Zealanders. (1997) (34)
Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial* (2011) (34)
PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. (2000) (34)
Leg ulcers in New Zealand: age at onset, recurrence and provision of care in an urban population. (2002) (34)
Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population. (2009) (33)
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial (2010) (33)
Blood pressure and the global burden of cardiovascular disease. (1999) (32)
The determinants of fat intake in a multi-ethnic New Zealand population. Fletcher Challenge--University of Auckland Heart and Health Study Management Committee. (1998) (30)
A clinical trial of the effect of aromatherapy on motivational behaviour in a dementia care setting using a single subject design. (1998) (30)
Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease: A Randomized Controlled Trial (2003) (30)
Differences between blood-pressure-lowering drugs (2000) (28)
Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens: An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials (2010) (28)
Risk Prediction in Patients With Heart Failure (27)
The New Zealand Blood Donors' Health Study: baseline findings of a large prospective cohort study of injury (2002) (27)
Collaborative overview (‘Meta-Analysis’) of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration (1999) (26)
Ethnic differences in blood pressure: findings from the Fletcher Challenge-Auckland University Heart and Health Study. (1996) (26)
Regional variation in the incidence of hip fracture in New Zealand. (1997) (26)
Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease. (2002) (26)
Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial. (1994) (25)
Global burden of blood pressure-related disease (2001) (2001) (25)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
The lowering of blood pressure after stroke (2001) (24)
Does capture‐recapture analysis provide more reliable estimates of the incidence and prevalence of leg ulcers in the community? (2002) (23)
Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults (2017) (23)
Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation (2003) (23)
The PROGRESS study: Rationale and design (1995) (23)
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
Atherosclerosis and left ventricular hypertrophy: persisting problems in treated hypertensive patients. (1998) (23)
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials (2017) (23)
Primary and secondary prevention of stroke. (1996) (23)
Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial (2014) (22)
Prevention of cardiovascular diseases in developing countries: agenda for action (statement from a WHO-ISH Meeting in Beijing, October 1999). (2000) (22)
Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group. (1997) (21)
Blood Pressure Lowering for the Prevention of Cognitive Decline in Patients with Cerebrovascular Disease (1997) (21)
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial (2014) (20)
Leg ulceration as a long-term complication of deep vein thrombosis. (2003) (20)
An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1999) (19)
Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. (1994) (19)
Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy (1998) (19)
CHRISTCHURCH CARDIOENDO-CRINE RESEARCH GROUP; AUSTRALIA-NEW ZEALAND HEART FAILURE GROUP. COMPARISON OF BT-YPE NATRIURETIC PEPTIDES FOR ASSESSMENT OF CARDIAC FUNCTION AND PROGNOSIS IN STABLE ISCHEMIC HEART DISEASE (2006) (18)
BLOOD PRESSURE LOWERING IN PATIENTS WITH CEREBROVASCULAR DISEASE: RESULTS OF THE PROGRESS (PERINDOPRIL PROTECTION AGAINST RECURRENT STROKE STUDY) PILOT PHASE (1996) (18)
Blood pressure and cardiovascular disease: tracing the steps from Framingham. (2010) (18)
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. (2015) (17)
The effects of antihypertensive drug treatment on the incidence of stroke and of coronary heart disease. (1989) (17)
IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
Blood pressure management in the 21st century: maximizing gains and minimizing waste. (2013) (17)
The J-Curve Phenomenon and the Treatment of Hypertension (1991) (17)
Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region (2009) (16)
Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. (2009) (16)
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS MRI Substudy (2005) (16)
A RANDOMIZED CONTROLLED TRIAL OF WEIGHT REDUCTION AND METOPROLOL IN THE TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS (1985) (16)
Attitudes and Practices of New Zealand Anaesthetists with Regard to Epidural and Subarachnoid Anaesthesia (1996) (15)
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial (2021) (15)
Introduction: The global burden of stroke (2002) (15)
Clinician's Manual on Blood Pressure and Stroke Prevention (2002) (15)
Pravastatin Reduces Total Mortality in Patients With Coronary Heart Disease and Average Cholesterol Levels: Relationship of Baseline Cholesterol and Treatment Effects in the LIPID Trial (1998) (15)
The associations of diastolic blood pressure with the risk of stroke in Western and Eastern populations. (1999) (14)
Does interleukin-18 or tumour necrosis factor-alpha have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand. (2010) (14)
Blood pressure reduction and the prevention of stroke (1991) (14)
Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India (2018) (14)
Treatment of high blood pressure in overweight patients. (1987) (14)
The PROGRESS trial three years later: time for more action, less distraction (2004) (14)
A user-centred home monitoring and self-management system for patients with heart failure: a multicentre cohort study. (2015) (14)
Migraine: a risk factor for motor vehicle driver injury? (1997) (14)
Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. (2000) (14)
Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration. (1999) (14)
Blood pressure lowering with fixed combination perindopril–indapamide: key findings from ADVANCE (2008) (13)
Industry-sponsored clinical trials in emerging markets: time to review the terms of engagement. (2013) (13)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Intensive glucose control in type 2 diabetes – Reply (2008) (13)
M-mode echocardiography: reproducibility of serial left ventricular measurements in subjects with normal ventricles and patients with congestive cardiomyopathy. (1983) (13)
Two decades of research on innovative models of care delivery for patients with heart failure: the end or just the beginning? (2012) (13)
Regional anaesthesia reduces perioperative mortality: results from an overview of randomised trials (2000) (12)
Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease. (1995) (12)
Change in Blood Pressure Variability Among Treated Elderly Hypertensive Patients and Its Association With Mortality (2019) (12)
Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors (1997) (12)
Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program (2017) (11)
Prevention of cardiovascular diseases in developing countries: agenda for action: statement from a WHO-ISH meeting in Beijing (1999) (11)
The HRT furore: getting the message right (2002) (11)
Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA (130th American Neurological Association) (2005) (11)
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event (2009) (10)
Study protocol: systematic review of the burden of heart failure in low- and middle-income countries (2012) (10)
A prospective cohort study of blood donors: methodological issues in the investigation of injuries and chronic diseases (1998) (10)
Use of major surgery in south India: A retrospective audit of hospital claim data from a large, community health insurance program. (2015) (10)
LightWeight IP Application Examples (2014) (9)
Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events. (2003) (9)
Selection bias in clinical research when subjects are excluded because of failure to estimate left ventricular mass by echocardiography. (1998) (9)
Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease (2007) (9)
Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group. (1998) (9)
PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee [corrected]. (1995) (9)
The global burden of blood pressure-related diseases (1999) (9)
Blood pressure levels and mortality from cerebrovascular disease in Australia and the United States. (1984) (8)
Blood pressure and the burden of coronary heart disease (2009) (8)
WEIGHT REDUCTION IN HYPERTENSION (1985) (8)
Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease (2007) (8)
Effects of Lidocaine on Ventricular Fibrillation, Asystole, and Early Death in Patients with Suspected Acute Myocardial Infarction (1987) (8)
Forty years of randomised trials in the New Zealand Medical Journal. (1996) (8)
China Rural Health Initiative – Sodium Reduction Study: the effect of a community-based sodium reduction program on 24hr urinary sodium and blood pressure in rural China (2013) (7)
HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION (1992) (7)
Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes MellitusNovelty and Significance (2015) (7)
Epidemiology and prevention of cardiovascular disease (2005) (7)
PROGRESS – perindopril protection against recurrent stroke study: status in July 1996 (1996) (7)
The burden of blood pressure related disease (2002) (7)
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
Antihypertensive Agents and Stroke Prevention (1994) (6)
Compression of Pulmonary Veins Between the Left Atrium and the Descending Aorta (2003) (6)
Blood Pressure Lowering In Diabetes: A Brief Review Of The Current Evidence And Description Of A New Trial (2001) (6)
ADVANTAGES AND DISADVANTAGES OF THE META-ANALYSIS APPROACH. DISCUSSION (1996) (5)
Cholestrol, coronary heart disease, and stroke in the Asia Pacific region (2007) (2007) (5)
The ADVANCE trial – Authors' reply (2008) (5)
Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study. (1997) (5)
Future Directions for Randomized Trials of Cardiovascular Disease Prevention in Hypertensive Patients (1990) (5)
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial (2021) (5)
Epidemiological research in cardiovascular disease in Australia: 1984. (1985) (5)
Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial (2008) (4)
High prevalence of chronic kidney disease in (2008) (4)
Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme (2015) (4)
The Saline vs. Albumin Fluid Evaluation (SAFE) Study (2018) (4)
PEP trial - Reply (2000) (4)
Global epidemiology of cardiovascular disease (2000) (4)
Blood pressure and the risk of recurrent vascular disease (1998) (3)
Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III (2008) (3)
Antiplatelet therapy and the prevention of thrombosis. (1996) (3)
Pravastatin therapy and the risk of stroke: results from the LIPID study (2000) (3)
surgery (HIPAID): randomised controlled trial ectopic bone formation after hip replacement ibuprofen for pain and disability related to Safety and efficacy of routine postoperative (2008) (3)
Responding to China's hypertensive crisis (2009) (2)
Management of raised blood pressure. (1994) (2)
Prevalence of hypertension in CHD patients in the asia-pacific region: the aspac study (2000) (2)
The predictive ability of different measures of kidney function: new data from the Progress study (2006) (2)
Lowering Cholesterol Levels in Patients with Coronary Heart-Disease - the 4s Trial Showed That Lowering High Cholesterol Levels Improves Survival in Patients with Coronary Heart-Disease - Do the Benefits Extend to Those with Average Cholesterol Levels (1995) (2)
06 The pulmonary embolism prevention (PEP) trial: effects of low-dose aspirin on major vascular events in hip fracture surgical patients (1999) (2)
Progress: Perindopril protection against recurrent stroke study: rationale, results and importance: perspective from the principle investigators (2003) (2)
Atherosclerosis and Left Ventricular Hypertrophy: Persisting Problems in Treated Hypertensive Patients (1998) (2)
Evidence from randomised controlled trials of antihypertensive drugs (1999) (2)
Prevention of cardiovascular morbidity and mortality in hypertension: benefits of blood pressure reduction and cholesterol lowering. (1989) (2)
THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA (2009) (2)
Cholesterol and total mortality (1992) (2)
New approaches for the prevention of vascular disease in Type 2 diabetes (2008) (1)
Perindopril protection against recurrent stroke study (PROGRESS) (2001) (1)
Carvedilol reduces left ventricular volumes in patients with heart failure of ischemic etiology (1996) (1)
Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease (2006) (1)
The Apolipoprotein E genotype and the risk of cerebral hemorrhage in stroke patients of Asian origin (2006) (1)
Abstract 204: Blood Pressure Reduction And Stroke Recurrence: The Progress Trial (2013) (1)
Beyond hypertension - the burden of blood pressure related disease (2002) (1)
Hypertension and cardiovascular disease (2000) (1)
Cuts to the NHMRC budget will undermine the health of all Australians — today and in the future (2011) (1)
Non-drug treatments of hypertension (1982) (1)
China Rural Health Initiative – Primary care provider study: A large cluster-randomized controlled trial of high cardiovascular risk management in rural China (2013) (1)
THE RELATIONS OF SERUM-CHOLESTEROL, BLOOD-PRESSURE, AND SMOKING HABIT TO CORONARY HEART-DISEASE IN A POPULATION WITH LOW MEAN CONCENTRATIONS OF SERUM-CHOLESTEROL (1989) (1)
New paradigm in hypertension management [Invited lecture] (2004) (1)
The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture (1999) (1)
The effects of body mass and alcohol consumption on blood pressure levels and the prevalence of hypertension in Australian men and women (1984) (1)
The critical examination of x-ray generating equipment in diagnostic radiology. (Guidance on the interpretation of the ionising radiations regulations 1985, regulation 32(2) a). (IPEM Report 79) (1999) (1)
Patient Preference for Ketamine: A Case Report of Multiple Anesthesias (1975) (1)
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons (2005) (1)
PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke (2021) (1)
PROGRESS in the treatment of stroke (2001) (1)
Polypills for the prevention of cardiovascular disease: a framework for wider use (2022) (1)
Lacunar stroke in PROGRESS study (2004) (1)
Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress (2022) (1)
Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial (2012) (1)
Methodological aspects: general discussion (1996) (1)
Blood pressure drugs cut death rate in diabetes (2007) (0)
Patterns and trends in motor vehicle related injury death rates in China: 1987-1997 (1999) (0)
Plenary lecture. ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes. Hotline session (2007) (0)
Cardiovascular risk in Asia: an overview [Invited lecture] (2007) (0)
Role of observational epidemiology in clinical trials (2005) (0)
The global burden of cardiovascular disease. Satellite Symposium: Modern approaches to protect target organs in patients at increased total cardiovascular risk [Invited lecture] (2006) (0)
Perindopril-based blood pressure lowering reduces major vascular and bleeding events in patients with cerebrovascular disease who use antithrombotic therapy: the PROGRESS trial (2011) (0)
The true effects of established risk factors of cardiovascular disease (1999) (0)
Lower blood pressure and the risk of recurrent stroke in patients with chronic kidney disease: results of the PROGRESS trial (2008) (0)
Faculty Opinions recommendation of Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. (2008) (0)
Global inequalities in cardiovascular healthcare: our greatest challenge (2007) (0)
Results of the second cycle of the Blood Pressure Lowering Treatment Trialists’ Collaboration (2003) (0)
Blood pressure, blood cholesterol, smoking. Disease control priorities in developing countries 2: Consultation of cardiovascular diseases. What do we know and what do we need to know for control CVD in developing countries? (2002) (0)
Author response for "Obesity as a risk factor for COVID ‐19 mortality in women and men in the UK Biobank: comparisons with influenza/pneumonia and coronary heart disease" (2020) (0)
Blood pressure and cardiovascular disease in the Asia Pacific region (2007) (2007) (0)
Treatment for high blood pressure: evidence and practice. (1998) (0)
[Keynote speaker] The role of academic health centers in developing global health priorities. John P. McGovern Award Lecture. (2010) (0)
[Letter to the Editor] ADVANCE Blood pressure lowering in diabetes (2009) (0)
Effects of calcium antagonists on CHD, CHF and stroke [Invited lecture] (2006) (0)
Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial (2012) (0)
Preventing cardiovascular events in diabetic patients: the ADVANCE study. Satellite Symposium (2007) (0)
PROGRESS main results. Satellite symposium "PROGRESS in Stroke Prevention" (2001) (0)
Results of recent trials of anti-hypertensive drugs.ALLHAT investigators meeting (2000) (0)
Invited lecture on Role of fixed dose combination in clinical practice: 3 perspectives (2005) (0)
Do men and women respond differently to blood pressure lowering treatment? prospective meta-analysis of randomised trials (2008) (0)
Blood pressure and vascular disease: a global perspective (2008) (0)
Health-related aspects of lifestyle in general hospital patients. (2010) (0)
[Keynote lecture - Plenary Session] Clinical Trials: interpretation (2008) (0)
POST HOC ANALYSIS : USE AND DANGERS IN PERSPECTIVE. DISCUSSION (1996) (0)
Effects of ACE inhibitors on athersclerosis - final results from the PART 2 trial (1999) (0)
Implications for chronic disease management in the Asia Pacific region. The Bangkok challenge: from conflict to cooperation and beyond [Invited lecture] (2007) (0)
Epidemiological Outlook. Cardiovascular Risk Management: Bayer’s Expertise in a Complex Area (2005) (0)
ADVANCE: Blood Pressure Lowering in Diabetes (Letter to the Editor) (2009) (0)
Serum triglycerides and coronary heart disease in Asia Pacific populations (2003) (0)
Connectiviety of CV risk factors: do we have enough epidemiological evidence [Invited lecture] (2005) (0)
Higher total serum cholesterol is associated with greater risk of coronary heart disease and ischemic stroke, but not haemorrhagic stroke: Evidence from the Asia Pacific Cohort studies collaboration (2002) (0)
Systolic pressure and pulse pressure as determinants of cardiovascular disease (1999) (0)
Epidemiology of BP related diseases in Asia and Australasia (2001) (0)
Renal outcome and microalbuminuria data from ADVANCE (2008) (0)
Blood pressure control for the prevention of cardiovascular disease in developing countries (1999) (0)
Experiences of Chronic Disease Prevention and Control during Social Transition (2011) (0)
Opportunities and chanllenges for conducting clinical trials outside the US and Western Europe - pathways and markets [Invited lecture] (2006) (0)
[Keynote speaker] Pragmatic trials: a bold new paradigm for sepsis research (2010) (0)
Effects of Antihypertensive Treatment on Coronary Artery Disease: Directions for Future Research (1991) (0)
Lowering Blood pressure in the non-diabetic: How far and with what? Advances in Diabetes, Vascular Disease and the Kidney [Invited speaker] (2010) (0)
National Heart Foundation Visiting Lecturer: The prevention of heart disease – So much achieved for so few (2011) (0)
The efficacy of lower blood pressure goals on the prevention of stroke in chronic kidney disease: data from the PROGRESS study (2007) (0)
The importance of co-existing CV risk factors (2006) (0)
Abstract 12563: Variation in Referral for Specialist Follow-Up and 30-Day Mortality in Patients Hospitalized With Heart Failure in England and Wales (2014) (0)
Vascular protective effects of ACE inhibitator-based blood pressure lowering-PROGRESS results. From hypertension to stroke - what is the connection? (2001) (0)
COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY (2007) (0)
The importance of co-existing cardiovascular risk factors. Preventive Cardiology Sympsoium [Invited lecture] (2006) (0)
Reduction in coronary events with pravastatin and proportion of treatment benefit explained by on-study LIPID levels in the LIPID study (2000) (0)
VALUE in the context of other recent trials of blood pressure lowering [Invited lecture] (2004) (0)
Smoking status and the risk of fatal coronary heart disease in Asian and Australisian populations (2003) (0)
retrospective driver injuries status: a cohort study with prospective and Motor vehicle driver injury and socioeconomic (2005) (0)
Worldwide epidemiologic data: coexistence of multiple risk factors (2006) (0)
Blood Pressure Trialists' Collaboration: Second cycle of overviews. Global Chapter Meeting of the Vascular Biology Working Group [Invited lecture] (2003) (0)
New frontiers in cardiovascular risk management: optimizing outcomes in patients with cardiovascular risks [Invited lecture] (2006) (0)
Results of the Pulmonary Embolism Prevention Trial (1999) (0)
Initiative for Cardiovascular Health Research in Developing Countries (IC Health) (Conference Paper) (2003) (0)
Preventing the growing burden of stroke (2002) (0)
Lowering Blood Pressure in Patients with Type 2 Diabetes Significantly Reduces the Risk of Death from Diabetic Complications Even in Patients with Normal Blood Pressure (2007) (0)
COST-EFFECTIVENESS CALCULATIONS FROM TRIALS. DISUCUSSION (1996) (0)
Overview of trials completed or in progress: what's resolved and what's not? (1996) (0)
ADVANCE: Blood Pressure Lowering in Diabetes (2009) (0)
Blood pressure lowering therapy (2002) (0)
Clinical drug development in Asia: challenges and opportunities [Invited lecture] (2007) (0)
Blood pressure and vascular disease: From observational studies to randomised trials and beyond (2008) (0)
CHINESE CONTRIBUTION TO TRIALS ON ANTIHYPERTENSIVE THERAPY. DISCUSSION (1996) (0)
Blood Pressure Lowering Treatment Trialists’ Collaboration: second cycle of overviews (2003) (0)
From Telemedicine to Wearables: The Impact of Technological Innovations on Global Health. Topic: Systematic Medical Appraisal, Referral and Treatment for NCDs (2016) (0)
Outcome trials in hypertension - implications for practice [Invited lecture] (2005) (0)
Hypertension trials - past, present and future (2000) (0)
Practical lessons from hypertension programmes on the Indian Sub Continent and China (2011) (0)
Effects of omatpatrilat on blood pressure and neurohormone levels among 723 individuals with CHD - the PACIFIC study (2001) (0)
Clinical Trials in Hypertension and Congestive Heart Failure (1986) (0)
Invited lecture. A framework for conducting trials with greater clinical relevance. designing clinical trials to change practice in thrombosis management sessions (2005) (0)
New perspectives in cardiovascular disease and its treatment (2002) (0)
ADVANCE Master Meeting I of the ADVANCE Glucose-Lowering Arm (2008) (0)
[OP.4A.11] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION (2017) (0)
Cost effective strategies for cardiovascular risk reduction — workshop (2003) (0)
METHODOLOGICAL ASPECTS : GENERAL DISCUSSION. DISCUSSION (1996) (0)
Renal and microalbuminuria data from ADVANCE (2009) (0)
“Frugal” healthcare innovation – a global research priority (2012) (0)
68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL (2012) (0)
Women as participants in cardiovascular trials (1986) (0)
Clinical trials, observational studies and the media (2002) (0)
Frugal innovation - The future of cardiovascular medicine (2012) (0)
Is there evidence ot support differences in outcome claims for different antihypertensive drug classes (2005) (0)
Cardiovascular disease in Asia - the present and the future [Invited lecture] (2006) (0)
P4932Elevated blood pressure and risk of mitral regurgitation (2017) (0)
Plenary lecture. Blood Pressure Trialists' Collaboration: results of the second cycle of analyses (2004) (0)
New insights from the blood pressure Lowering Treatment Trialists' Collaboration [Invited lecture] (2006) (0)
3.1 Stroke, coronary heart disease, cholesterol and blood pressure (1997) (0)
PEP trial (2000) (0)
Reductions in the risk of vascular events and stroke in patients with and without chronic kidney disease; new data from the PROGRESS trial (2006) (0)
Blood pressure lowering for the prevention of vascular complications of non-insulin dependent diabetes mellitus (2000) (0)
The newest WHO-ISH meta-analysis and VALUE trial: The importance of lowering blood pressure in preventing cardiovascular events [Invited lecture] (2004) (0)
Cardiovascular disease: a neglected yet avoidable threat to develpment and the alleviation of poverty [Invited lecture] (2004) (0)
Population trends in cardiovascular risk factors: new insights [Invited lecture] (2005) (0)
Blood pressure and secondary prevention of stroke (1999) (0)
Treatment of hypertensive patients is more than blood-pressure control (2003) (0)
Revaluation of the effects of rennin-angiotensin system inhibitors : new results from the BPLTTC (2006) (0)
Outcome trials - completing the picture [Invited lecture] (2006) (0)
The occurence of leg ulcers in Auckland: Results of a population of a population-based study (2002) (0)
Conventional risk factors: evolving concepts of risk and expanding strategies for prevention (2000) (0)
Medical treatment for hypertension: evidence from clinical trials. ISH satellite symposium (2000) (0)
Can NT-proBNP monitoring help prevent cardiovascular disease? Recent Advances in Cardiovascular Disease (2007) (0)
Stroke prevention - the role of blood pressure lowering [Invited lecture] (2006) (0)
Global burden of cardiovascular disease. National Heart Foundation Lecture (1999) (0)
BLOOD PRESSURE LOWERING FOR THE SECONDARY PREVENTION OF STROKE : RATIONALEAND DESIGN FOR PROGRESS. DISCUSSION (1996) (0)
A major step forward in stroke prevention: therapeutic implications of the PROGRESS trial (2001) (0)
Effects of antihypertensive treatment on outcome: a meta-analysis (2001) (0)
Global Healthcare: Innovative Affordable Strategies for Health (2011) (0)
The importance of blood pressure reduction: evidence from epidemiological studies and clinical trials (2003) (0)
Determinants of Atherosclerosis in Hypertensives (1998) (0)
[PP.13.01] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE (2016) (0)
Our Greatest Challenge (0)
Blood Pressure Trialists' Collaboration: secnond cycle of overviews [Invited lecture] (2003) (0)
Sustainable healthcare for the 21st century. (2013) (0)
World Health Organisation-International Society of Hypertension Blood Lowering Treatment Trialists' Collaboration (2000) (0)
Risk-based prevention programmes for primary care: what evidence do we need? (2011) (0)
PROGRESS - from blood pressue lowering to prevention of stroke (2001) (0)
Blood pressure and cardiovascular disease in the Asia Pacific region (Chinese Journal of Cardiology) (2006) (0)
Faculty Opinions recommendation of Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. (2009) (0)
EDITORIAL Measuring Mäori health status accurately - more needs doing Tony Blakely, (2002) (0)
Author Index / Subject Index Vol. 4 (suppl 1) 1994 (1994) (0)
Facts and fallacies in the history of antihypertensive treatment. Calcuim antagonist story (2005) (0)
Keynote lecture. The global impact of the cardiovascular disease epidemic (2006) (0)
Non communicable diseases: the challenges for developing countries (2000) (0)
707-2 Effects of Carvedilol on Left Ventricular Function and Exercise Performance in Patients with Heart Failure of Ischemic Etiology (1995) (0)
Debate: the results of surrogate endpoint trials should influence clinical practice (against the motion). Preventive cardiolgoy - principles and practice (2000) (0)
Blood Pressure as Risk Factor for Several Diseases Blood Pressure and Cardiovascular Disease (2015) (0)
Chapter 9: Renal and microalbuminuria data from ADVANCE (2009) (0)
Clinical implications of PROGRESS: questions and answers (2003) (0)
Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
Burden of cardiovascular diseases and diabetes (2003) (0)
Is there greater VALUE of lowering BP or medication choice? Integrating Lipid and BP management into a New Paradigm for Intensive Cardiovascular Prevention [Invited lecture] (2004) (0)
Preventing cardiovascular events in diabetic patients: the ADVANCE study [Invited lecture] (2007) (0)
Epidemiological aspects of hypertension and dyslipidaemia. burden of hypertension and dyslipidaemia in cardiovascualr disease [Satellite Symposium: Invited lecture] (2004) (0)
Satellite Symposium: Invited lecture on A multifactorial approach to treatment - what do the meta-analyses tell us? Maning multiple risk factors in cardiovascular disease: new insights and future directions (2004) (0)
Differences in outcome claims for different drug classes (2005) (0)
General claims for anti-hypertension drugs (2005) (0)
PATIENT PREFERENCE FOR KETAMINE (1975) (0)
WHO-ISH Blood Pressure Lowering Treatment Trialists' Collaboration: main results from first cycle of analyses (2000) (0)
Subject Index, Vol. 47, 1987 (1987) (0)
Blood pressure targets in the hypertensive patient symposium (2001) (0)
PROGRESS main results. Symposium on Seconday Stroke Prevention (2001) (0)
Hypertension – time to give it up? (2008) (0)
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials. (2022) (0)
Blood pressure and vascular complications of diabetes (2001) (0)
New evidence from trials of blood pressure lowering - implications for patient care (2006) (0)
Results of principal endpoint studies, ongoing studies and expected future results (2002) (0)
ROUTINE PERIOPERATIVE NSAIDS PROPHYLAXIS FOR ECTOPIC BONE FORMATION AFTER HIP REPLACEMENT SURGERY (HIPAID). A RANDOMISED CLINICAL TRIAL (2009) (0)
Prolonged and sustained reduction in total and coronary mortality in patients assigned pravastatin in the LIPID trial during two further years of follow-up (2000) (0)
Blood pressure management in the 21st century: maximising the gains, minimising the waste (2013) (0)
Blood pressure, ischaemic stroke and myocardial infarction (2000) (0)
Blood-pressure-lowering meta-analysis revisited: placing VALUE and other new trials in perspective [Invited lecture] (2004) (0)
Cardiovascular diseases in Asia and the Pacific - causes and consquences (2001) (0)
O3-04-08 Effect of white matter lesions on incidence of dementia in patients with stroke (2006) (0)
Designer drugs for the doctor to Asia'a poor ; Polio, TB, tropical disease give way to diabetes, stroke, road trauma . . . (2013) (0)
Pregnancy and leg ulceration. (2004) (0)
Targeting total CV risk in clinical practice. Satellite symposium (2007) (0)
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes (2007) (0)
Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 11 Medica (2018) (0)
Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. (2010) (0)
Bloodpressure andriskof stroke inpatients with cerebrovascular disease (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephen W. Macmahon?

Stephen W. Macmahon is affiliated with the following schools:

University of Auckland

Stephen W. Macmahon's Academic­Influence.com Rankings

Stephen W. Macmahon's Degrees

Why Is Stephen W. Macmahon Influential?

Stephen W. Macmahon's Published Works

Published Works

What Schools Are Affiliated With Stephen W. Macmahon?

Stephen W. Macmahon's AcademicInfluence.com Rankings